Cargando…
Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study
Precise tacrolimus treatment in transplanted patients is achieved in the clinical setting by performing therapeutic drug monitoring (TDM) and consequently adjusting therapy. The aim of this study was to retrospectively analyze the variability in tacrolimus blood levels throughout 2 years of observat...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354451/ https://www.ncbi.nlm.nih.gov/pubmed/32492825 http://dx.doi.org/10.3390/jpm10020047 |
_version_ | 1783558087111606272 |
---|---|
author | Pallio, Giovanni Irrera, Natasha Bitto, Alessandra Mannino, Federica Minutoli, Letteria Rottura, Michelangelo Pallio, Socrate Altavilla, Domenica Alibrandi, Angela Marciano, Maria Concetta Righi, Maria Mannucci, Carmen Arcoraci, Vincenzo Squadrito, Francesco |
author_facet | Pallio, Giovanni Irrera, Natasha Bitto, Alessandra Mannino, Federica Minutoli, Letteria Rottura, Michelangelo Pallio, Socrate Altavilla, Domenica Alibrandi, Angela Marciano, Maria Concetta Righi, Maria Mannucci, Carmen Arcoraci, Vincenzo Squadrito, Francesco |
author_sort | Pallio, Giovanni |
collection | PubMed |
description | Precise tacrolimus treatment in transplanted patients is achieved in the clinical setting by performing therapeutic drug monitoring (TDM) and consequently adjusting therapy. The aim of this study was to retrospectively analyze the variability in tacrolimus blood levels throughout 2 years of observation in 75 transplanted patients and to investigate if tacrolimus blood levels correlate with presence of genetic polymorphisms, thus modifying tacrolimus pharmacokinetics. CYP3A5*1 (G6986A), CYP3A4*1B (A392G), CYP3A4*22, ABCB1 (C3435T; C1236T; G2677A/T), SLCO1B1 (T521C), polymorphisms were analyzed. Based on the effect of their genotypes, patients were stratified into 5 groups: (1) reduced tacrolimus metabolism (RM), (2) increased metabolism (IM), (3) transporters polymorphisms (TM), (4) metabolism and transporter polymorphisms (AM) and (5) no mutations (Wild Type, WT). The percentage of the samples out of therapeutic range was significantly higher in the IM group than in the WT group (p = 0.001), as well as compared to the TM group (p = 0.004). Only IM pattern (p = 0.015) resulted as an independent predictor of number of tacrolimus blood levels out of therapeutic range. RM pattern (p = 0.006) was inversely related to the administered dose. Therefore, genotyping could become a standard practice before tacrolimus prescription thus decreasing side effects, increasing efficacy and reducing the economic burden for the national health system. |
format | Online Article Text |
id | pubmed-7354451 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73544512020-08-05 Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study Pallio, Giovanni Irrera, Natasha Bitto, Alessandra Mannino, Federica Minutoli, Letteria Rottura, Michelangelo Pallio, Socrate Altavilla, Domenica Alibrandi, Angela Marciano, Maria Concetta Righi, Maria Mannucci, Carmen Arcoraci, Vincenzo Squadrito, Francesco J Pers Med Article Precise tacrolimus treatment in transplanted patients is achieved in the clinical setting by performing therapeutic drug monitoring (TDM) and consequently adjusting therapy. The aim of this study was to retrospectively analyze the variability in tacrolimus blood levels throughout 2 years of observation in 75 transplanted patients and to investigate if tacrolimus blood levels correlate with presence of genetic polymorphisms, thus modifying tacrolimus pharmacokinetics. CYP3A5*1 (G6986A), CYP3A4*1B (A392G), CYP3A4*22, ABCB1 (C3435T; C1236T; G2677A/T), SLCO1B1 (T521C), polymorphisms were analyzed. Based on the effect of their genotypes, patients were stratified into 5 groups: (1) reduced tacrolimus metabolism (RM), (2) increased metabolism (IM), (3) transporters polymorphisms (TM), (4) metabolism and transporter polymorphisms (AM) and (5) no mutations (Wild Type, WT). The percentage of the samples out of therapeutic range was significantly higher in the IM group than in the WT group (p = 0.001), as well as compared to the TM group (p = 0.004). Only IM pattern (p = 0.015) resulted as an independent predictor of number of tacrolimus blood levels out of therapeutic range. RM pattern (p = 0.006) was inversely related to the administered dose. Therefore, genotyping could become a standard practice before tacrolimus prescription thus decreasing side effects, increasing efficacy and reducing the economic burden for the national health system. MDPI 2020-06-01 /pmc/articles/PMC7354451/ /pubmed/32492825 http://dx.doi.org/10.3390/jpm10020047 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pallio, Giovanni Irrera, Natasha Bitto, Alessandra Mannino, Federica Minutoli, Letteria Rottura, Michelangelo Pallio, Socrate Altavilla, Domenica Alibrandi, Angela Marciano, Maria Concetta Righi, Maria Mannucci, Carmen Arcoraci, Vincenzo Squadrito, Francesco Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study |
title | Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study |
title_full | Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study |
title_fullStr | Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study |
title_full_unstemmed | Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study |
title_short | Failure of Achieving Tacrolimus Target Blood Concentration Might Be Avoided by a Wide Genotyping of Transplanted Patients: Evidence from a Retrospective Study |
title_sort | failure of achieving tacrolimus target blood concentration might be avoided by a wide genotyping of transplanted patients: evidence from a retrospective study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354451/ https://www.ncbi.nlm.nih.gov/pubmed/32492825 http://dx.doi.org/10.3390/jpm10020047 |
work_keys_str_mv | AT palliogiovanni failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy AT irreranatasha failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy AT bittoalessandra failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy AT manninofederica failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy AT minutoliletteria failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy AT rotturamichelangelo failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy AT palliosocrate failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy AT altavilladomenica failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy AT alibrandiangela failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy AT marcianomariaconcetta failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy AT righimaria failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy AT mannuccicarmen failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy AT arcoracivincenzo failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy AT squadritofrancesco failureofachievingtacrolimustargetbloodconcentrationmightbeavoidedbyawidegenotypingoftransplantedpatientsevidencefromaretrospectivestudy |